Organization · Venture Capital
The Conscious Fund
The Conscious Fund is a venture capital firm based in London, UK, specializing in early-stage investments in psychedelic medicine and mental health solutions. It emphasizes ethical investment practices and supports companies addressing conditions like depression and addiction.
Overview
What The Conscious Fund does
What The Conscious Fund is
The Conscious Fund is a venture capital firm based in London, UK, specializing in early-stage investments in psychedelic medicine and mental health solutions. It emphasizes ethical investment practices and supports companies addressing conditions like depression and addiction.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 22, 2026
Official channels
Find The Conscious Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
The Conscious Fund as a funder
Investment thesis
The Conscious Fund focuses on ethical venture capital, investing in early-stage companies within the psychedelic medicine and mental health sectors. It emphasizes a profit-sharing model that benefits both portfolio companies and charitable causes.
Focus narrative
The Conscious Fund primarily invests in early-stage companies, focusing on the pre-seed and seed stages. Its investment strategy centers around sectors related to health and wellness, with a particular emphasis on psychedelic medicine, including psilocybin, ketamine, and MDMA. The fund adopts an index-style approach, supporting a range of companies that contribute to the emerging psychedelic and mental health landscape.
Value beyond capital
The Conscious Fund adds value to its portfolio companies through ethical investment practices and a unique profit-sharing model, returning a percentage of profits to the companies and supporting charitable causes. Additionally, the fund provides access to a network of resources and expertise in the psychedelic and mental health sectors.
Terms and economics
- Typical check
- $100,000–$2,000,000
- Sweet spot
- $500,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
Notable portfolio companies include: ATAI Life Sciences: A clinical-stage biopharmaceutical company focused on mental health. Cybin: A psychedelic medicine company dedicated to drug development. Numinus: A provider of mental health and psychedelic-assisted therapy. MagicMed Industries: A platform specializing in psychedelic chemistry. Wesana Health: A company focused on psilocybin-based mental health solutions.
Common questions
What to know about The Conscious Fund
Upseed classifies The Conscious Fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 22, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.